Otsuka Chemical (India) Private Limited

       Welcome to Otsuka Chemical (India) Private Limited, a leading pharmaceutical intermediate company that has been at the forefront of innovation since 2006. Our primary objective is to produce Advance Cephalosporin Drug Intermediate, commonly known as “GCLE,” which is widely used in the Indian Pharmaceutical Industry. The Indian market was the obvious choice to settle into, due to the huge potential of its pharmaceutical industry and the fact that it has the largest consumer base in the world. This provides us with the opportunity to not only grow as a company but to also provide our high-quality products to as many people as possible, thereby maximizing their level of satisfaction and improving their quality of life. By developing and adhering to a set of preset rules, committees, and procedure manuals, we hope to uphold our contractual obligation to act in the interests of our stakeholders.To accomplish this, we take into account corporate policies and environmental conservation efforts, abide by societal norms, and behave in an ethical manner. To find out more about our business, our offerings, and our dedication to quality, we encourage you to browse our website. We appreciate you choosing Otsuka Chemical (India) Private Limited as your first choice. With the above aim, the company set up a fully automatic DCS controlled plant at Kotputli, in Rajasthan, India. The plant has come into full operations since May 2008.with an object to produce Advance Cephalosporin Drug Intermediate namely “GCLE”. Since Indian Pharmaceutical Industry is the largest consumer of GCLE across the world, and we wanted to be close to the customers, Otsuka decided to set up GCLE manufacturing facility in India. GCLE is a major raw material to produce some vital Cephalopodan antibiotics such as, Cefixime, Cefdinir, Cefprozil and Cefpodoxime, We are well supported by world class research facilities and having world class manufacturing facility in India. Our focus is to provide the best se